Search Results - "weidner, Morgan T."

Abstract 5454: Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer by Chumsri, Saranya, Larson, Joseph J., Adams, Daniel L., Tenner, Kathleen S., Tang, Cha-Mei, Weidner, Morgan T., Arnold, Amanda N., Haley, Dana L., Advani, Pooja, Sideras, Kostandinos, Moreno-aspitia, Alvaro, Perez, Edith A., Knutson, Keith L.

“…Abstract Background: Activation of the RAS/MAPK pathway is associated with reduced tumor-infiltrating lymphocytes and poor outcomes in triple-negative breast…”
Get full text

Abstract P4-01-17: Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer by Chumsri, Saranya, Larson, Joseph J., Tenner, Kathleen S., He, Jun, Polley, Mei-Yin, weidner, Morgan T., Arnold, Amanda N., Haley, Dana, Advani, Pooja, Sideras, Kostandinos, Moreno-Aspitia, Alvaro, Perez, Edith A., Knutson, Keith L.

“…Abstract Background: Previous studies demonstrated that activation of the RAS/MAPK pathway is associated with reduced tumor-infiltrating lymphocytes and poor…”
Get full text